Skip to content

Drug interactions

Imatinib + Norgestrel

Severity: Minor

Imatinib and Norgestrel: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Imatinib is a moderate CYP3A4 inhibitor and may raise norgestrel concentrations. This could increase progestogenic adverse effects, although the clinical impact is probably modest. Imatinib is also teratogenic, so reliable contraception matters in treated patients.

What this interaction means in plain words

Imatinib and Norgestrel have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Imatinib belongs to Oncology; Norgestrel belongs to Endocrine.

Evidence level: Low

Why it happens

Imatinib inhibits CYP3A4-mediated metabolism of norgestrel.

What to do

No routine dose change is needed; monitor for progestogenic adverse effects such as breakthrough bleeding, headache or mood changes. Continue effective contraception during imatinib therapy.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Imatinib and Norgestrel, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Imatinib with Norgestrel?

MediHelp rates the interaction as minor. Imatinib and Norgestrel have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Imatinib is a moderate CYP3A4 inhibitor and may raise norgestrel concentrations. This could increase progestogenic adverse effects, although the clinical impact is probably modest. Imatinib is also teratogenic, so reliable contraception matters in treated patients.

How serious is the interaction between Imatinib and Norgestrel?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed; monitor for progestogenic adverse effects such as breakthrough bleeding, headache or mood changes. Continue effective contraception during imatinib therapy.

What other medicines interact with Imatinib?

MediHelp also lists interactions of Imatinib with, for example, Lomitapide, Lonafarnib, Amobarbital. The full list is on the Imatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in